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Balanced protein synthesis and degradation are crucial for
proper cellular function. Protein synthesis is tightly coupled to
energy status and nutrient levels by the mammalian target of
rapamycin complex 1 (mTORC1). Quality of newly synthesized
polypeptides is maintained by the molecular chaperone and
ubiquitin-proteasome systems. Little is known about how cells
integrate information about the quantity and quality of transla-
tional products simultaneously. We demonstrate that cells dis-
tinguish moderate reductions in protein quality from severe
proteinmisfolding usingmolecular chaperones to differentially
regulate mTORC1 signaling. Moderate reduction of chaperone
availability enhances mTORC1 signaling, whereas stress-in-
duced complete depletion of chaperoning capacity suppresses
mTORC1 signaling. Molecular chaperones regulate mTORC1
assembly in coordination with nutrient availability. This mech-
anism enables mTORC1 to rapidly detect and respond to envi-
ronmental cues while also sensing intracellular proteinmisfold-
ing. The tight linkage between protein quality and quantity
control provides a plausible mechanism coupling protein mis-
folding with metabolic dyshomeostasis.
The eukaryotic translational initiation machinery is a tightly
controlled system that regulates protein synthesis based on
many factors including the availability of growth factors, nutri-
ents, and glucose (1). Accordingly, when there are shortages of
these factors, protein synthesis stalls. The molecular pathway
responsible for linking the environmental cues and transla-
tional control is the mammalian target of rapamycin (mTOR)3
signaling pathway (2, 3). mTOR is an evolutionarily conserved
serine/threonine kinase that links environmental status with a
host of other cellular processes such as cellular growth, prolif-
eration, metabolism, autophagy, and translational control (4).
mTOR is present in two functionally and structurally distinct
multiprotein complexes termed mTOR complex 1 (mTORC1)
and mTOR complex 2 (mTORC2) (5). mTORC1 consists of
mTOR, Raptor, PRAS40, and mLST8 and is sensitive to rapa-
mycin (6, 7). mTORC2 contains mTOR, Rictor, mSIN1, and
mLST8 and is not directly inhibited by rapamycin (8). The piv-
otal role of mTOR in cellular and organismal homeostasis is
reflected in the fact that dysregulation of this pathway results in
unrestrained signaling activity in mammals and is associated
with the occurrence of disease states including inflammation,
cancer, and diabetes (9).
Acommonthemeunderlyingavarietyof stressconditions is the
accumulation of misfolded proteins in cells. In response to stress,
or heat shock, cells increase the expression of molecular chaper-
ones. Molecular chaperones are essential for protecting nascent
polypeptide chains from misfolding, facilitating co- and post-
translational folding, assisting in assembly and disassembly of
macromolecular complexes, and regulating translocation (10, 11).
The concentration of molecular chaperones is titrated closely to
the folding requirements within a specific cell type (12), and it has
longbeen suggested that there is a close correlationbetween stress
response and nutrient signaling pathways (13). Adverse environ-
mental and metabolic conditions (including nutrient limitation,
hypoxia, andDNAdamage) result in adecrease inmTORC1activ-
ity (14). In addition to conserving cellular energy, the reduction in
translation that accompanies thedecreasedmTORC1activity also
prevents the synthesis of unwanted proteins that could interfere
with the cellular stress response.However, the effect of stress con-
ditions on mTORC1 signaling appears to be ambiguous. Depen-
ding on exposure length, dose/concentration of the stressor, and
timebetweenstress stimulusandassay, stress conditionsmayhave
distinct effects onmTOR-dependent cellular events. Several stress
conditions, such asUV light exposure, H2O2 addition, heat shock,
and fluid sheer stress, have been shown to cause an initial increase
of mTOR-dependent S6K phosphorylation, with decreases in
mTORC1 activity occurring after prolonged or severe exposure
(15–17). The importance of this initial up-regulation ofmTORC1
activity upon imposition of stressors is not readily apparent. Sim-
ilarly, it remainsunclearhowseeminglydisparate stressconditions
can elicit a similar response of mTORC1 signaling.
The interface between chaperone-mediated stress response
and mTORC1-mediated nutrient signaling can be viewed as a
central homeostatic mechanism. Despite the obvious impor-
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tance of this interface, however, the interrelationships between
metabolic and cell stress signaling remain poorly understood,
and currently, little is known about the role of cytosolic molec-
ular chaperones in the regulation of nutrient signaling path-
ways. Survival ofmulticellular organisms depends on the ability
to protect against a variety of stressors and the ability to adjust
protein synthesis for developmental need. However, themolec-
ular connection between chaperone-mediated stress response
and the mTORC1-mediated nutrient signaling pathway re-
mains poorly understood. In particular, it is completely unclear
how mTORC1 signaling responds to the accumulation of mis-
folded proteins in cells. We now demonstrate that accumula-
tion of misfolded proteins in cells, under both acute and
chronic conditions, triggersmTORC1 signaling and transiently
increases protein synthesis. This is in sharp contrast to other
adverse conditions that suppress mTORC1 signaling and may
represent an unrecognized cellular adaptation in response to
protein quality fluctuations. Importantly, we provide evidence
that molecular chaperones coordinate with nutrients to regu-
late mTORC1 complex assembly. Our results indicate that
mTORC1, by sensing chaperone availability in cells, maintains
protein homeostasis by linking protein quality and quantity
control in cells.
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents—HEK293 cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal
bovine serum (FBS) and cultured at 37 °C. HSF1/ and
HSF1/mouse embryonic fibroblasts were kindly provided by
I. J. Benjamin (University of Utah). L-Azetidine-2-carboxylic
acid (AZC), L-canavanine, proline, and geldanamycinwere pur-
chased from Sigma; [35S]methionine was from Amersham
Biosciences; -galactosidase (-gal) and -actin monoclonal
antibodies were from Sigma; anti-Hsp70 (SPA810) and anti-
Hsp90 (SPA840) were from StressGen; antibodies for phos-
phorylated and total eIF2 (antibodies 9721 and 9722), S6
(antibodies 2215 and 2217), p70 S6 kinase 1 (S6K1) (antibodies
9234 and 9202), 4EBP1 (antibodies 9459 and 9452), Raptor,
(antibody 4978), and Rictor (antibody 2140) were from Cell
Signaling. -Gal activity wasmeasured by the Galacto-Star sys-
tem (Applied Biosystems). Mammalian expression vectors for
-gal and a truncated version of bovine serum albumin (cBSA)
were described previously (26). Constructs containing Myc-
mTOR, Myc-Raptor, and Myc-Rictor were obtained from the
D. M. Sabatini laboratory via Addgene Inc.
Immunoblotting—Cells were lysed on ice in TBS buffer (50
mM Tris-HCl, 150 mM NaCl, 1 mM EDTA) containing a prote-
ase inhibitor mixture tablet, 1% Triton X-100, and 2 units/ml
DNase. After incubating on ice for 30 min, the lysates were
heated for 10min in SDS-PAGE sample buffer (50mMTris-HCl
(pH 6.8), 100 mM dithiothreitol, 2% SDS, 0.1% bromphenol
blue, 10% glycerol). Proteins were resolved on SDS-PAGE and
transferred to Immobilon-P membranes (Millipore). Mem-
branes were blocked for 1 h in TBS containing 5%BSA followed
by incubation with primary antibodies. After incubation with
horseradish peroxidase-coupled secondary antibodies, immu-
noblots were developed using enhanced chemiluminescence
(Amersham Biosciences). All experiments were performed at
least three times.
Metabolic Labeling—Cells were radiolabeled with [35S]Met
(100 Ci/ml) in complete medium for the indicated times.
After washing with PBS containing excess cold Met (6.7 mM),
cells were frozen in dry ice. Whole cell lysates were made as
described in the above section. After resolving on SDS-PAGE,
the gel was fixed and dried. Both the image and the quantitation
were obtained using a PhosphorImager (Amersham Bio-
sciences). All experiments were performed at least three times.
Immunoprecipitation—Cells were lysed on ice in TBS buffer
(50mMTris-HCl (pH 7.5), 150mMNaCl, 1mMEDTA, protease
inhibitor mixture tablet) containing 1% Triton X-100, 1%Non-
idet P-40, or 0.3%CHAPS as indicated. Cell lysates were cleared
by centrifugation at 5,000  g for 5 min. Supernatants were
incubated with anti-Myc agarose beads at 4 °C for 60 min.
Immunoprecipitates were washed four times with lysis buffer
and eluted using 1 SDS-PAGE sample buffer. Samples were
resolved on SDS-PAGE followed by immunoblotting. All
experiments were performed at least three times.
Fluorescence Imaging—HEK293 cells expressing YFP-mTOR
were cultured in glass-bottomed dishes at 37 °C in 5% CO2 in
DMEM containing 10% fetal bovine serum. Fluorescence
recovery after photobleaching (FRAP) was performed at room
temperature on a confocal microscope (LSM 510; Carl Zeiss,
Jena, Germany) using a40 oil objective and scan zoom 3. A
rectangular region of interest was bleached with 60 iterations
and 100% laser power (514-nm argon laser). One image was
captured before bleaching. An image was taken every second
(514-nm argon laser at 5% power) after bleaching over a 50-s
period. For each time point, the fluorescence intensity of the
photobleached region of interest was determined using LSM
510 software. Fluorescence loss in photobleaching (FLIP)
experiments were also performed on the LSM 510 laser scan-
ning confocal system. Cells were repeatedly bleached at the
same defined region, and the whole cell was imaged at intervals
of 15 s.
For Föster resonance energy transfer (FRET) experiments,
living HEK293 cells expressing Venus-mTOR and Raptor-Ce-
rulean were imaged using the Zeiss LSM510 microscope sys-
tem. FRET was detected by the method of acceptor photo-
bleaching. Venus and Cerulean were excited by laser light at a
514- or 458-nm wavelength, respectively, by using the multi-
track function of the LSM 510 system. To perform multitrack
acquisition, two “track” configurations were preset: track 1,
acceptor (Venus-mTOR) filter sets (excitation with 514 nm
laser; emission passed through anNFT515 dichroic splitter and
a 530–600-nm bandpass filter to PMT 3 (photomultiplier tube
3)); track 2, donor (Raptor-Cerulean) filter set (excitation with
458 nm laser; emission reflected off 515 dichroic splitter and
directed through a 470–500-nm bandpass filter to PMT 2).
Images from each track were displayed in separate image chan-
nels. Cells were then bleached with the laser set at 514 nm and
at maximum power for 300 iterations (which corresponds to
80% bleaching), after which postbleaching images were
acquired. The fluorescence intensity of donor and acceptor
was determined by LSM 510 software before and after pho-
tobleaching. After background subtraction, the apparent
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FRET efficiency was calculated as: apparent FRET effi-
ciency  ((CFPafter  CFPbefore)  YFPbefore) 
((CFPafter  YFPbefore)  (CFPbefore  YFPafter))  1, in
which the relative CFP increase due to YFP bleaching is cor-
rected for the fraction of YFP bleached. The apparent FRET
efficiency was finally expressed relative to control measure-
ments in cells expressing the CFP-YFP fusion protein




intracellular adaptation to protein quality variances, we used
amino acid analogs to induce protein misfolding. The compet-
itive incorporation between normal amino acids and their ana-
logs enables relatively precise manipulation of the extent of
global proteinmisfolding (18, 19).We followed the fate of-ga-
lactosidase (-gal) synthesized in the presence of the proline
analog AZC. The quality and quantity of -gal in transfected
HEK293 cells were determined respectively by measuring
enzyme activity and by immunoblotting with an antibody spe-
cific for -gal. 10 mM AZC, a sublethal but growth-inhibiting
concentration, dramatically reduced -gal activity but caused
only a slight decrease in the total amount of synthesized-gal in
cells (Fig. 1,A and B). This discordance is likely due to accumu-
lation ofmisfolded, enzymatically inactive-gal in cells (19). To
minimize the global disturbance of cellular functions by mis-
folded proteins, we performed similar experiments using lower
concentrations of AZC. Surprisingly, in the presence of 1 mM
AZC, we found an increase in both
the activity and the total amount of
-gal (Fig. 1, A and B). Although
the -gal activity was increased
12.5%, the total amount of -gal
was elevated 30%. It is likely that
not all of the increased-gal protein
is functional in the presence ofAZC.
We considered the possibility
that protein translation is increased
in cells in the presence of certain
concentrations of AZC. To test this
possibility, we measured the global
translation rate by pulsing cells with
[35S]methionine in the presence
of AZC. 10 mM AZC markedly
reduced 35S incorporation as com-
pared with cells treated with the
same amount of vehicle (50% at 60
min labeling; Fig. 1C). In contrast,
the presence of 1 mM AZC resulted
in 20% increase in translation at
60min of labeling (Fig. 1C). The pat-
tern of translational products as
determined by gel fractionation was
largely the same in the presence or
absence of AZC except that high
doses of AZC induced the appear-
ance of several additional bands
(likely Hsp70, Fig. 1C, arrow). Taken together, these data sug-
gest that the presence of AZC induces cellular stress and
dynamically alters global protein translation.
The incorporation of AZC into synthesizing polypeptides is
thought to reduce thermal stability and induce misfolding in a
dose-dependentmanner. Itwas therefore surprising to find that
translational regulation under these circumstances exhibits a
biphasic pattern rather than a gradient of suppression. To con-
firm that these effects are due to the disturbance of quality of
nascent proteins and not to other physiologic responses to
AZC, we examined the effects of the arginine analog L-canava-
nine. Treatment of HEK293 cells with L-canavanine resulted in
a similar increase in -gal levels and [35S]methionine incorpo-
ration, although at a higher concentration than that required
for AZC (data not shown). The differential dose response could
be due either to the fact that AZC is more potent than L-cana-
vanine in altering structural conformations of proteins (19) or
to different levels of analog incorporation into nascent proteins
(20). In either event, it is likely that the quality of translational
products, rather than the concentration of applied amino acid
analogs, determines the status of translational regulation.
Regulation of Protein Synthesis in Response to Protein Mis-
folding Involves mTORC1—Extensive studies have been
devoted to the identification of the mechanisms involved in
translational repression under various stress conditions (1). For
example, many different types of stress trigger the phosphory-
lation of eukaryotic initiation factor-2 (eIF2) at residue Ser-
51, resulting in a decrease of translation initiation (21).We thus
examined the phosphorylation status of eIF2 in cells treated
FIGURE 1. Effects of amino acid analogs on protein translation. A, HEK293 cells were transfected with
plasmids encoding -gal. 2 h after transfection, AZC was added into the medium with the final concentration
as indicated. Cell aliquots were harvested at 8, 16, and 24 h after transfection. The -gal activity in the whole cell
lysates was determined by chemiluminescent assay. B, the total amount of -gal in the same sample as in A was
determined by immunoblotting using a -gal monoclonal antibody. -Actin was used as a loading control, and
Hsp70 was used as a measure of stress response. C, HEK293 cells were pretreated with AZC for 30 min before
labeling with [35S]methionine. The global translation was followed by resolving newly synthesized proteins on
a 10% SDS-PAGE. Arrow, approximate size of Hsp70. D, the incorporation of 35S was quantitated by a Phos-
phorImager. Values are mean  S.D.
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with AZC at increasing doses and for increasing times. Consis-
tent with an AZC-induced stress response in cells, higher doses
and longer treatments of AZC caused a gradient increase of
eIF2 phosphorylation in cells (Fig. 2A). No biphasic pattern of
eIF2 phosphorylation was detected over a dose range of more
than 1,000-fold (from 10 M to 16 mM) during the 8-h time
course. These observations suggest that regulatory nodes inde-
pendent of eIF2 are responsible for enhanced protein synthe-
sis in the presence of low concentrations of the amino acid
analogs.
We next examined ribosomal protein S6, the phosphoryla-
tion of which is closely correlated to translation initiation (22).
Interestingly, S6 phosphorylation exhibited a remarkable
biphasic pattern in the presence of AZC; higher doses and lon-
ger treatments suppressed S6 phosphorylation, whereas lower
doses triggered its phosphorylation (Fig. 2B). Similar results
were obtained using L-canavanine (supplemental Fig. 1). The
phosphorylation of S6 is mediated by p70 S6K1, one of the best
characterized targets ofmTORC1 (3, 4, 23). Consistentwith the
phosphorylation status of S6, the presence of AZC caused
biphasic phosphorylation of S6K1 atThr-389, the target residue
of mTORC1 (Fig. 2, C and D). Thus, mild reduction in the
quality of nascent proteins triggers mTORC1 kinase activity,
whereas severe protein misfolding suppresses it.
Amino acids are positive regulators of mTORC1 signaling,
although the nature of the sensor remains elusive (24). Several
lines of evidence ruled out the possibility that enhanced
mTORC1 signaling under low concentrations of AZC is due to
altered distribution of normal amino acids in the cytosol. First,
our studies were performed in nutrient-rich medium. Second,
adding equivalent amounts of proline into the medium did not
reproduce the effects of AZC on the phosphorylation status of
mTORC1 targets (Fig. 2D). Third, we observed no detectable
changes in overall protein degradation in the presence of 1 mM
AZC (supplemental Fig. 2). Considering that protein synthesis
is increased under these conditions (Fig. 1C), it is unlikely that
there are concomitant increases of intracellular amino acid lev-
els under these conditions.
Reduced Chaperone Availability Enhances mTORC1 Sig-
naling—Having shown thatmild proteinmisfolding induced by
amino acid analogs enhanced mTORC1 signaling, we were
interested in assessing the effect of other forms of protein mis-
folding on mTORC1 signaling. We first ectopically expressed
cBSA, a protein incapable of acquiring its normal conformation
in the reducing cytosolic environment (25, 26). Chronic accu-
mulation of cBSA in the cytoplasm triggered the phosphoryla-
tion of S6K1 in a dose-dependent manner, whereas equivalent
expression of -gal had negligible effects (Fig. 3A). This result
indicates that misfolding of a single protein is able to modulate
mTORC1 signaling.
We next examined the effects of heat shock, another cellular
stressor, on mTORC1 signaling using mouse fibroblasts.
Shortly after heat shock treatment (42 °C), we observed a rapid
increase of S6K1 phosphorylation (within 30 min; Fig. 3B). The
S6K1 phosphorylation was maintained at levels above baseline
during heat shock (a slight decrease in S6K1 phosphorylation
FIGURE 2. Modulation of mTORC1 signaling pathway by amino acid analog-induced protein misfolding. A–C, HEK293 cells were treated with AZC at
concentrations from 0 to 16 mM. Cell aliquots were harvested every 2 h up to 8 h. Whole cell lysates were immunoblotted using antibodies against total or
phosphorylated (circled P) eIF2 (A), S6 (B), and S6K1 (C). After quantitation by densitometry, the fraction of phosphorylated eIF2 was adjusted by total eIF2.
The phosphorylation status was normalized relative to the no treatment control (omitted for clarity) and converted into a heat map by TreeView (right).
D, HEK293 cells were treated with AZC or proline at concentrations from 0 to 16 mM for 4 h. See also supplemental Figs. 1 and 2.
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after 60 min was possibly due to the degradation of total S6K1
molecules as the percentage of S6K1 phosphorylated remained
the same). Notably, the surge of S6K1 phosphorylation
occurred much earlier than the heat shock-induced Hsp70
expression (30 min versus 60 min; Fig. 3B). Therefore, it is
unlikely that increased Hsp70 expression per se triggered S6K1
phosphorylation.
In contrast to prolongedheat shock, during recovery at 37 °C,
S6K1 phosphorylation was gradually reduced to basal levels,
although a similar amount of Hsp70 was induced as prolonged
heat shock (Fig. 3C). This result led us to hypothesize that chap-
erone molecules like Hsp70 negatively regulate mTORC1 sig-
naling, at least transiently. Based on this hypothesis, we pre-
dicted that mTORC1 should remain responsive to misfolded
proteins in the absence of chaperone gene expression. Consis-
tent with this model, treating cells with the protein synthesis
inhibitor cycloheximide (CHX) shortly after heat shock did not
prevent S6K1 phosphorylation but did completely block the
chaperone induction (Fig. 3D). In contrast, rapamycin treat-
ment to blockmTOR completely inhibited the S6K1 phosphor-
ylation, indicating that the stress-induced S6K1 phosphoryla-
tion occurred through a mTORC1-mediated pathway.
To substantiate the observation that reduced chaperone
availability enhances mTORC1 signaling, we used RNAi-medi-
ated knockdown to directly manipulate chaperone levels in
cells. Because the basal expression level of Hsp70 is very low
under normal conditions, we chose Hsp90 as the knockdown
target in these experiments. Due to the abundance of Hsp90
in cells, only 50% reduction was obtained for Hsp90 and
Hsp90 after a 48-h transfection of small interference RNA
(Fig. 3E). However, this moderate
reduction of Hsp90 levels was still
sufficient to induce a significant
increase in S6K1 phosphorylation.
Therefore, chronic reduction of
chaperone availability, without
acute stress exposure, is able to
trigger mTORC1 signaling.
Complete Depletion of Chaperon-
ing Capacity Suppresses mTORC1
Signaling—Our discovery that re-
ducing Hsp90 expression enhances
mTORC1 signaling is in sharp con-
trast to the recent report that Hsp90
positively regulates S6K1 phosphor-
ylation in mammalian cells (27).
Ohji et al. (27) demonstrated that
geldanamycin (GA), a potent and
specific Hsp90 inhibitor, suppresses
binding of Raptor to Hsp90 and
decreases S6K1 phosphorylation.
To resolve this apparent contradic-
tion in observations, we re-exam-
ined the effects of GA on mTORC1
signaling by performing a time
course experiment using different
doses of GA. We found that only
prolongedGA treatment (2 h) and
high concentrations (10 M) caused the suppression of S6K1
phosphorylation (Fig. 4A). Remarkably, there was an initial
rapid surge of S6K1 phosphorylation shortly after GA treat-
ment (within 30min) followed by a continual decrease in phos-
phorylation, similar to the enhanced mTORC1 signaling
observed after heat shock treatment (Fig. 3B). This triggering
effect was still noticeable even with GA treatment at low con-
centrations (1 M; Fig. 4A). Notably, the amount of total S6K1
protein was reduced in the presence of GA, suggesting that
S6K1 is one of the clients of Hsp90.
The biphasic pattern of S6K1 phosphorylation after GA
treatment is reminiscent of our observations of S6K1phosphor-
ylation in the presence of the amino acid analog AZC (Fig. 2).
Both treatments share a common feature: a potent heat shock
response followed by deficient chaperone functionality, pre-
sumably because newly synthesized chaperone molecules are
nonfunctional in the presence of AZC orGA.We reasoned that
both GA and AZC treatments eventually depleted chaperone
availability by permanently blocking the functionality of chap-
eronemolecules. Therefore, the twophases inmTORC1 signal-
ing observed in our previous experiments might represent a
switch of chaperone availability frommodest reduction to total
depletion.
To test this hypothesis, we used an immortalized fibroblast
cell line derived from HSF1/ mice (20, 28). HSF1/ cells
cannot induce a heat shock response under stress conditions
and therefore experience diminished chaperone availability
under prolonged stress conditions. Heat shock (42 °C) induced
efficient Hsp70 expression in the HSF1/ cells but not the
HSF1/ cells (Fig. 4B). Both cell groups exhibited a rapid
FIGURE 3. Reduced chaperone availability enhances mTORC1 signaling. A, HEK293 cells were transfected
with increasing amounts of -gal (0.02, 0.1, and 0.5 g/well in six-well plates) or cBSA (0.1, 0.5, 2.5 g/well).
Whole cell lysates were immunoblotted using antibodies as indicated. Circled P indicates phosphorylation.
B, mouse fibroblasts were incubated at 42 °C for the indicated times. Whole cell lysates were immunoblotted
using antibodies as indicated. C, mouse fibroblasts were incubated at 43 °C for 30 min followed by recovery at
the 37 °C for the indicated times. Whole cell lysates were immunoblotted using antibodies as indicated. No HS,
no heat shock. D, mouse fibroblasts were incubated at 43 °C for 30 min followed by recovery at the 37 °C for the
indicated times in the absence or presence of 100 M cycloheximide (CHX). For rapamycin treatment, 20 nM
rapamycin was added into the medium prior to heat shock treatment. E, HEK293 cells were transfected with
small interference RNA against Hsp90 or Hsp90. After a 72-h transfection, whole cell lysates were immuno-
blotted using antibodies as indicated.
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increase in S6K1 phosphorylation shortly after heat shock, fur-
ther confirming the notion that reduced chaperone availability
enhances mTORC1 signaling. In contrast to HSF1/ cells, in
which the S6K1 phosphorylation was sustained at high levels
during heat shock, HSF1/ cells demonstrated a sudden
depletion of S6K1 phosphorylation after the initial increase
(Fig. 4B). This pattern is strikingly similar to that of GA treat-
ment, where an increase inmTORC1 signaling occurredwithin
60 min followed by a drastic reduction around 90 min after
treatment (Fig. 4, A and B).
In an effort to prove the essential role of molecular chaper-
ones in mTORC1 signaling, we introduced chaperones back
intoHSF1/ cells using recombinant adenoviruses. After pro-
longed heat shock treatment, only the viruses expressingHsp90
andHsp70, but not the control virus expressing-gal, were able
to rescue the S6K1 phosphorylation (Fig. 4C). Taken together,
our results indicate that complete depletion of chaperone
capacity suppresses mTORC1 signaling.
Molecular Chaperones Are Required for Appropriate
mTORC1 Assembly—To determine how changing chaperone
availability affects mTORC1 signaling, we first examined the
integrity of mTORC1 following treatment with either AZC or
heat shock. Despite considerable effort, we failed to detect any
difference in the amount of Raptor coimmunoprecipitatedwith
mTOR under these conditions (supplemental Fig. 3). We sus-
pect that this is a reflection of the fact that protein-protein
interactions detected within the cell lysates may not faithfully
represent themTORC1 integrity in living cells. It is noteworthy
that many commonly used detergents readily break down
mTOR complexes in lysates (7). It has been suggested that
hydrophobicity of the residues at the interface of mTOR-Rap-
tor plays a role inmTORC1 assembly. Consistent with this idea,
the interaction of these proteins can be preserved in zwitteri-
onic detergents such as CHAPS (7). Surprisingly, we observed
that Hsp90 was associated with mTOR only after extraction
using Triton X-100 or Nonidet P-40 (Fig. 4D). 0.3% CHAPS,
which maintained mTORC1 integrity, largely abolished Hsp90
binding. Raptor exhibited the same detergent-dependent,
mutually exclusive pattern ofHsp90 versusmTORbinding (Fig.
4E). These observations indicate that Hsp90 interacts with iso-
lated components of mTORC1, but not with the assembled
complex itself. These characteristics fit with the adopted
molecular chaperone definition, a protein that has a functional
effect on another protein-protein complex without becoming
part of the final operative structure.
Hsp90 is among the most abundant proteins in cells, occu-
pying1–2%of total cellular proteins. Themajor role ofHsp90
is to suppress protein aggregation by retaining target proteins
within the cytosol in the soluble form (29). Recent biochemical
analysis indicates thatmTORC1may oligomerize to form com-
FIGURE 4. Depleted chaperone availability suppresses mTORC1 signaling. A, mouse fibroblasts were treated with 1 or 10 M GA for the indicated times.
Whole cell lysates were immunoblotted using antibodies as indicated. Circled P indicates phosphorylation. B, HSF1/ and HSF1/ cell lines were incubated
at 42 °C for the indicated times. Whole cell lysates were immunoblotted using antibodies as indicated. C, HSF1/ cells were infected with 20 multiplicity of
infection recombinant adenovirus expressing the indicated genes for 24 h. Infected cells were then incubated at 42 °C for the indicated times. Whole cell lysates
were immunoblotted using antibodies as indicated. D, HEK293 cells were transfected with Myc-mTOR followed by extraction with 1% Triton X-100 (TX-100), 1%
Nonidet P-40 (NP-40), or 0.3% CHAPS. The mTOR complexes were precipitated using anti-Myc antibodies. Both lysates and immunoprecipitates were immu-
noblotted using antibodies as indicated. E, HEK293 cells were transfected with plasmids encoding Myc-mTOR or Myc-Raptor. Similar experiments as in D were
performed to determine the chaperone binding affinity. F, HSF1/ and HSF1/ cell lines were incubated at 42 °C for the indicated times. Whole cell lysates
were fractionated using 1% Triton X-100 into soluble and insoluble fractions. Immunoblotting was performed using antibodies as indicated. See also
supplemental Fig. 3.
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plexes of higher order, although the significance of this oligo-
merization remains to be determined (3). The aggregation-
prone property of mTOR complexes prompted us to test
whetherHsp90 plays a role in preventingmTORC1 fromaggre-
gation and subsequent inactivation. We fractionated lysates of
heat-shocked HSF1/ and HSF1/ cells into soluble and
insoluble fractions. CHAPS detergent was used tomaintain the
mTORC1 integrity. The majority of mTOR and Raptor mole-
cules were recovered in the soluble faction of HSF1/ cells
(Fig. 4F). In contrast, heat shock treatment resulted in progres-
sive accumulation of mTOR and Raptor in the insoluble frac-
tion of HSF1/ cells. Therefore, diminished chaperone avail-
ability due to thermal stress causes relocation of mTOR and its
regulatory components into the insoluble fraction, presumably
by aggregation.
mTORC1 Undergoes Dynamic Regulation in Living Cells—
Following heat shock treatment, a portion of mTOR became
insoluble in HSF1/ cells (Fig. 4F). Interestingly, the time
course of changing solubility of mTORmirrored the enhanced
mTORC1 signaling in these cells (Fig. 4B). It is intuitively
appealing to assume that reduced chaperone availability results
in more mTORC1 complex formation and thereby enhances
mTORC1 signaling, whereas complete chaperone depletion
leads to severe mTORC1 aggregation and consequently sup-
pressesmTORC1 signaling (Fig. 4F). Therefore, to elucidate the
pattern of mTORC1 signal regulation, we analyzed mTORC1
dynamics in living cells.
We employed live cell imaging to visualize the behavior of
mTORC1 in response to changing chaperone availability. After
attempting multiple strategies to create functional mTOR
fusion proteins, we validated a successful solution by fusing one
copy of YFP to the NH2 terminus of mTOR and including a
flexible linker between them. The recombinant YFP-mTOR
was able to bind endogenous Raptor and endogenous Rictor
(supplemental Fig. 4). These observations indicated that the
YFP-mTOR fusion protein maintains the functionality of
endogenous mTOR by forming complexes with other regula-
tory components.
We investigated the dynamics of mTOR under three differ-
ent conditions. First, we established themobility of YFP-mTOR
under normal growth conditions. These experiments provide
basic information about whether the majority of mTOR mole-
cules in cells are in the free formorwithin the complex. Second,
we asked how mTOR dynamics change upon reduction of
chaperone availability, such as after heat shock treatment.
Third, we investigated the effects of nutrients on mTOR
dynamics to gain insight into the regulatory mechanisms of
mTORC1 signaling.
To analyze the mobility of YFP-mTOR under normal condi-
tions, we first performed fluorescence loss in photobleaching
(FLIP). For FLIP, a small region of the cell YFP-mTOR fluores-
cence was repeatedly photobleached. Over time, YFP-mTOR
fluorescence in the entire cell was steadily and uniformly lost,
whereas fluorescence of adjacent cells was unaffected (Fig. 5A).
These results indicate that YFP-mTOR has access to the region
of photobleaching, without any significant immobilized popu-
lation.We then performed FRAP to quantitate themobility rate
of YFP-mTOR. Under normal growth conditions, the t1⁄2 of
YFP-mTOR recovery is 4.5 s (Fig. 5B). Parameters that
directly influence t1⁄2 include viscosity (or crowdedness of the
environment), size of the protein complex, protein-protein
interactions, or combinations of these variables (30). Thus,
evenmodest changes in t1⁄2 can be due to biologically significant
changes.
We investigated the consequence of thermal stress on the
mobility of YFP-mTOR. Incubation of cells at 42 °C for 60 min
resulted in a significant reduction of YFP-mTORmobility (Fig.
5, A and B) with a resulting t1⁄2  30 s. This was not due to the
increased crowdedness of cytoplasm after heat shock because
native YFP demonstrated little change in mobility under the
same conditions (Fig. 5B). These data support the notion that
heat shock treatment results in mTOR protein oligomerization
or complex formation that in turn decreases the diffusibility of
mTOR within the cell.
Given the fact that mTORC1 complex formation is a regu-
lated process, we predicted that the presence of nutrients
should facilitate mTORC1 complex formation, whereas with-
drawal of nutrients should enhance the mTOR mobility
because of less complex formation. To test this possibility, we
incubated cells in PBS for 10 min before FLIP and FRAP anal-
ysis. Remarkably, the absence of nutrients led to much higher
mobility of YFP-mTOR in cells (Fig. 5, C and D) with t1⁄2  1 s.
Once again, this was not due to the changing viscosity of cytosol
in the absence of nutrients because the mobility of YFP protein
demonstrated little change in the absence of nutrients. There-
fore, both nutrients and chaperone availability affect mTOR
mobility, possibly by regulating mTOR complex formation.
Further supporting this notion, recent studies report that nutri-
ent signaling relies onRagGTPase-mediatedmTORC1 recruit-
ment into lysosome-associated Rheb, forming an active super
mTORC1 complex (31–33).
Both Nutrients and Chaperones Regulate the mTOR-Raptor
Interaction—Having found that both nutrients and chaperones
control YFP-mTOR mobility in living cells, we asked whether
this mobility change represented mTORC1 complex forma-
tion. To this end, we employed FRET to examine the mTOR-
Raptor interaction (31). Because Cerulean and Venus are a bet-
ter combination for FRET analysis, we chose this pair of GFP
variants as a donor and an acceptor (32). Studies from cryo-EM
have indicated that TOR andKOG1 (the yeast homolog of Rap-
tor) form a head-to-tail ring structure (33). We therefore fused
Cerulean to the carboxyl terminus of Raptor (Raptor-Cerulean)
and fused Venus to the amino terminus of mTOR (Venus-
mTOR) so that both CFP and YFP can be in close proximity
when mTOR and Raptor form a complex (Fig. 5E). Raptor-
Cerulean functions as endogenous Raptor, as indicated by its
capability to coimmunoprecipitate with endogenous mTOR
(supplemental Fig. 5).
We first examined the co-localization of mTOR and Raptor
by co-transfecting HEK293 cells with plasmids encoding
Venus-mTOR and Raptor-Cerulean. As shown in Fig. 5F, both
mTOR and Raptor had an almost exclusive cytosolic localiza-
tion. Because of the rapid mobility of mTOR in cells, co-local-
ization with Raptor does not necessarily mean the formation of
an mTORC1 complex. We therefore used the acceptor photo-
bleaching method to measure the FRET efficiency between
mTORC1 Links Protein Quality and Quantity Control
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mTORandRaptor. In comparisonwith a positive FRET control
(FLIPE) in which both Venus and Cerulean were fused in a
single polypeptide (33), we observed 20% of FRET signal for
mTOR-Raptor under normal growth conditions (Fig. 5G). In
complete agreement with the altered mobility of mTOR, nutri-
ent withdrawal dramatically suppressed FRET efficiency,
whereas heat shock treatment almost doubled the FRET effi-
ciency (Fig. 5G). These results indicate that both nutrients and
chaperone availability control mTORC1 complex formation.
Molecular Chaperones Coordinate with Nutrient Signals in
Regulating mTORC1 Signaling—The dynamic assembly of
mTORC1 complexes implies that the formation of mTORC1
relies on recycling of existing but not newly synthesized com-
ponents. Supporting this notion, mTOR demonstrated a very
low turnover rate (t1⁄2  8 h) in cells under normal growth con-
ditions (supplemental Fig. 6). These data are consistent with a
model inwhich nutrients triggermTORC1 complex formation,
whereas molecular chaperones provide a continuous supply of
responsive mTOR components. This dynamic remodeling
mechanism indicates a strong coordination between nutrients
and chaperones in controlling mTORC1 signaling. We have
repeatedly demonstrated the indispensable role of chaperones
in nutrient-mediated mTORC1 signaling (Fig. 4, A and B). To
test whether hyperactive mTORC1 signaling is able to circum-
vent the requirement of chaperones, we treated cells with high
concentrations of insulin (200 nM). After prolonged GA treat-
ment (to inhibit Hsp90), cells were totally resistant to insulin
stimulation (Fig. 6A). Long term GA treatment inevitably
caused S6K1degradation, but the phosphorylation ablationwas
farmore rapid than the diminishing total levels of S6K1. Similar
FIGURE 5. mTORC1 dynamics in living cells. A, YFP-mTOR-transfected HEK293 cells were heat-shocked by incubating at 42 °C for 1 h. FLIP analysis was
performed to measure the mobility of mTOR. B, YFP-N1- or YFP-mTOR-transfected HEK293 cells were heat-shocked by incubating at 42 °C for 1 h. FRAP analysis
was performed to measure the mobility of mTOR. C, YFP-mTOR-transfected HEK293 cells were incubated in PBS for 30 min before FLIP analysis. D, YFP-N1 or
YFP-mTOR-transfected HEK293 cells were incubated in PBS for 30 min before FRAP analysis. DIC, differential interference contrast. E, diagram of interaction
between Venus-mTOR and Raptor-Cerulean (modified from Ref. 33). F, HEK293 cells were co-transfected with plasmids encoding Venus-mTOR and Raptor-
Cerulean. Co-localization of both proteins was examined using blue channel for Raptor and yellow channel for mTOR. G, HEK293 cells were co-transfected
with plasmids encoding Venus-mTOR and Raptor-Cerulean. FRET efficiency was calculated as the percentage of positive control FLIP. See also
supplemental Figs. 4 and 5. Error bars indicate S.E.
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results were obtained using TSC2/ mouse embryonic fibro-
blasts in which mTORC1 activity is constitutively active (34),
indicating that chaperones are required for mTORC1 activity
even under conditions of maximal upstream activation of
mTORC1.
We next examined whether reducing chaperone availability
alone is able to trigger mTORC1 signaling. We blocked
mTORC1 upstream signals by applying a PI3K inhibitor
LY294002 beforeGA treatment. As shown in Fig. 6B, PI3K inhi-
bition completely prevented the initial surge of S6K1phosphor-
ylation shortly after GA treatment. Thus, reducing chaperone
availability alone does not automatically lead to enhanced
mTORC1 signaling. Instead, it relies on the presence of
upstream signals such as PI3K-Akt. Consistent with heat shock
treatment, GA-induced increase of S6K1 phosphorylation was
also rapamycin-sensitive (Fig. 6B).
To define the minimal requirement of upstream signals for
GA-inducedmTORC1signaling,we examinedS6K1phosphor-
ylation under either serum depletion or nutrient withdrawal.
Interestingly, serum depletion did not prevent mTORC1 from
activation after GA treatment (Fig. 6C). Only nutrient with-
drawal after a 10-min PBS incubation completely suppressed
GA treatment-induced mTORC1 signaling. Taken together,
our results indicate that nutrients and chaperones rely on each
other in controlling mTORC1 signaling.
Enhanced mTORC1 Signaling in Mice with Accumulation of
Misfolded Proteins—The chaperone-mediated dynamic re-
modeling of mTORC1 prompted us to examine whether the
chronic accumulation of misfolded proteins in mice also
enhances mTORC1 signaling. CHIP (carboxyl terminus of
Hsp70/Hsp90-interacting protein) has been identified as an
important quality control ubiquitin ligase (35, 36). In the
absence of CHIP, the global chaperone network is challenged
by the accumulation of misfolded proteins (26, 37). Mice lack-
ing CHIP have a markedly reduced life span, along with accel-
erated age-related pathophysiological phenotypes (38). We
examined mTORC1 signaling in various tissues isolated from
CHIP/ mice and wild-type littermates.We observed that the
phosphorylation of S6K1 on Thr-389 was markedly increased
in CHIP/ mice (Fig. 7A). This is quite specific because the
phosphorylation of PDK1 remained unchanged. These results
indicate that the accumulation of misfolded proteins in mice
also induces mTORC1 signaling.
DISCUSSION
The results presented in this report point to a new paradigm in
the regulationofmTORC1signaling inwhichchaperoneavailabil-
ity directly affects mTORC1 signaling (Fig. 7B). Under normal
growth conditions, mTORC1 activity relies on the coordination
between molecular chaperones and nutrients. However, in the
absence of chaperone availability,
mTORC1 is unresponsive to nutrient
stimulation. Conversely, higher levels
of nutrients or reduced chaper-
one availability result in increased
mTORC1 singling. Thus, mTORC1
perceives proteotoxic stress based
on an order-of-severity sensing
mechanism.
mTORC1 Links Protein Quality
and Quantity Control—The initial
increase of mTORC1 signaling
upon exposure to adverse condi-
tions was first reported over a dec-
ade ago. Work by the Blenis group
(16) demonstrated that heat shock
treatment unexpectedly increased
phosphorylation of S6K1 in mouse
fibroblasts, a finding corroborated
FIGURE 6. Coordination between molecular chaperone and nutrients in
regulating mTORC1 signaling. A, TSC2/ and TSC2/ cells were treated
with 10 M GA treatment followed by immunoblotting using antibodies as
indicated. For insulin stimulation, TSC2/ cells were preincubated in the
presence of 200 nM insulin prior to GA treatment. Circled P indicates phosphor-
ylation. B, mouse fibroblasts were treated with 50 M LY294002, 20 nM rapa-
mycin, or an equal amount of dimethyl sulfoxide (DMSO) for 10 min prior to 10
M GA treatment. Whole cell lysates were immunoblotted using antibodies as
indicated. C, mouse fibroblasts were incubated in serum-free medium over-
night or in PBS for 30 min prior to 10 M GA treatment. See also
supplemental Fig. 6.
FIGURE 7. Accumulation of misfolded proteins triggers mTORC1 signaling in mice. A, immunoblotting
analysis of tissue samples from CHIP/ and CHIP/ mice at 3 months of age. Homogenates were prepared
from brain, heart, muscle, lung, and liver. Protein extracts were resolved by SDS-PAGE and blotted for antibod-
ies as indicated. Circled P indicates phosphorylation. B, proposed model for the coordination between molec-
ular chaperones and nutrients in regulating mTORC1 signaling. Both chaperones and nutrients control the
balance between mTORC1 assembly and disassembly. Under conditions of excess nutrition or reduced chap-
erone availability, the increased mTORC1 signaling provides an explanation about how chronic stress fuels
metabolic dyshomeostasis.
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by Lin et al. (39) in 1997. Likewise, multiple studies have dem-
onstrated that H2O2 treatment of cells regulates S6K activity in
a dose- and time-dependent manner (40, 41), similar to our
results using amino acid analog treatment. The initial up-regu-
lation of mTORC1 signaling upon imposition of stressors
should not be viewed as the cell misinterpreting a life-threaten-
ing insult. Rather, this feature enables the cell to distinguish
physiological fluctuations in the quality of translational prod-
ucts from the devastating accumulation of misfolded proteins.
It is generally accepted that global protein translation is sup-
pressed in response to severe stress conditions, but little is
known about how cells respond to fluctuations in the quality of
translational products. Like the variation of nutrient availability
in the environment, there is a wide fluctuation in the quality of
synthesized proteins during cell growth and organismal devel-
opment. Based on our observations, we propose that once the
buffering capacity of chaperones is exceeded, mTORC1 kinase
activity is quickly attenuated. Thus, the positive regulation of
mTORC1 signaling by misfolded proteins represents an unrec-
ognized cellular adaptation in response to reduced protein
quality.
mTORC1 Senses Chaperone Availability—Consistent with
other reports (14, 27), we demonstrate here that severe stress
conditions suppress mTORC1 signaling. Interestingly, the
transition from up-regulation to down-regulation occurs rap-
idly (Fig. 4, A and B). We reason that there is a threshold of
chaperone availability for the mTORC1-mediated sensing
mechanism. It is likely that folding status of mTOR determines
the threshold. mTOR and other regulator components like Rap-
tor are chaperone clients, as evidenced by the selective binding to
Hsp90when not forming the complex. In agreementwith the role
of Hsp90 in the ordered assembly and disassembly of large multi-
subunit complexes (42), this binding shields the hydrophobic
region of interacting components that maintains their solubility.
Lack of chaperone availability may result in mTOR aggregation.
Indeed, we observed a progressive change of mTOR solubility in
heat-shocked HSF1/ cells (Fig. 4D). This provides an explana-
tion for the unresponsiveness of mTORC1 to high insulin levels
under the depletion of chaperone availability.
Dynamic Remodeling of mTORC1—mTOR forms a huge
complex (up to 2 MDa) with other subunits to achieve signal
transmission (4, 43). Such multicomponent complexes pres-
ent special challenges for modulatory signaling pathways,
which must sense both increasing and decreasing signal
intensities and must also terminate and reinitiate signaling
efficiently. A dynamic mode of mTORC1 complexes would
fulfill this regulatory requirement. According to this scheme,
termination of mTORC1 signaling would not require a sep-
arate mechanism but rather would be an intrinsic conse-
quence of continuous disassembly of mTORC1. Indeed, we
observed a high degree of mobility of mTOR molecules
within the crowded cell interior, suggesting that mTORmol-
ecules undergo rapid exchange between the complexes and
free subunits (Fig. 5). Importantly, mTOR mobility is
directly affected by both nutrients and chaperone availabil-
ity. FRET analysis further confirmed that the changing
mobility of mTOR is due to mTOR-Raptor interaction.
Although it is challenging to recapitulate the mTORC1
dynamics in cell lysates using a biochemical approach (due to
possible altered chaperone functionality in solution, deter-
gent-affected protein-protein interactions, and a lack of lipid
hydrophobicity), we conclude from our findings that
mTORC1 complex assembly is a highly dynamic process inside
cells,whichconsistsof anefficient “ondemand”assemblybynutri-
ents and a continuous disassembly by molecular chaperones.
Analogous to chaperone-regulated HSF1 functionality, the
dynamic remodeling ofmTORC1 signaling not only ensures tight
control, dynamic range, and a rapidly reversible response in sens-
ing upstream signals but provides an elegant mechanism linking
protein quality and quantity control in cells. The interconnection
of different signaling pathways that feed back through a shared
pool of chaperones provides the recurrent framework for adapta-
tion and survival of cells in a changing environment.
Coordination between Nutrients and Chaperones in Regulat-
ing mTORC1 Signaling—As illustrated in Fig. 7B, chaperone-
mediated mTORC1 disassembly coordinates with nutrient sig-
naling-triggered assembly. This mechanism allows continuous
sensing of extracellular nutrients and intracellular protein
homeostasis. It remains to be determined how chaperone mol-
ecules actively remodel the mTORC1 complex. HSPs may sim-
ply “disaggregate” the mTORC1 complex while maintaining a
continuous supply of signaling components. An important
implication of the model of mTORC1 regulation presented in
this study is the synergistic effect of nutrient overload and chap-
erone stress inmetabolic dyshomeostasis. UnrestrainedmTOR
activity in mammals is associated with the occurrence of dis-
ease states including inflammation, cancer, and diabetes (23).
By contrast, decreased mTOR signaling by genetic or pharma-
ceutical approaches (such as rapamycin) has been shown to
extend lifespan in a variety of organisms (44–47). Interestingly,
a robust stress response is also required for life span extension
in these organisms (48, 49). Therefore, there is a close correla-
tion between stress response and nutrient signaling in regulat-
ing metabolic homeostasis.
Under physiological conditions, depletion of chaperone
availability is rare. In contrast, chronic reduction of chaperone
functionality often occurs during aging processes (12). The up-
regulation of mTORC1 signaling after reduction of chaperone
availability could be beneficial at the initial stage to maintain
protein homeostasis. However, prolongedmTORC1 activation
might cause metabolic dysregulation. Consistent with this
notion, CHIP/ mice exhibited accelerated aging phenotypes
as well as increased mTORC1 signaling (38). It is possible that
accumulation of misfolded proteins might fuel aging processes
by modulating the mTORC1 signaling pathway.
In summary, our results unveiled a molecular linkage
between protein quality and quantity control in cells. Further
understanding of the interaction between stress response and
the mTOR signaling pathway may provide opportunities for
therapeutic avenues to aging and age-related diseases.
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